DE1494846U - - Google Patents

Info

Publication number
DE1494846U
DE1494846U DENDAT1494846D DE1494846DU DE1494846U DE 1494846 U DE1494846 U DE 1494846U DE NDAT1494846 D DENDAT1494846 D DE NDAT1494846D DE 1494846D U DE1494846D U DE 1494846DU DE 1494846 U DE1494846 U DE 1494846U
Authority
DE
Germany
Prior art keywords
nmh
wich
nad
serves
ähoraoaame
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1494846D
Other languages
German (de)
English (en)
Publication of DE1494846U publication Critical patent/DE1494846U/de
Active legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DENDAT1494846D Active DE1494846U (enrdf_load_stackoverflow)

Publications (1)

Publication Number Publication Date
DE1494846U true DE1494846U (enrdf_load_stackoverflow)

Family

ID=799279

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1494846D Active DE1494846U (enrdf_load_stackoverflow)

Country Status (1)

Country Link
DE (1) DE1494846U (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
LU90865I2 (fr) Hydrochlorure d sibutramine ses d-riv-s et ses sels pharmaceutiquement acceptables en particulier le monohydrate d'hydrochlorure de sibutramine
RU97119646A (ru) Способы и составы для модулирования сексуальной реакции человека
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
PL1638539T3 (pl) Kompozycje farmaceutyczne zawierające czułe na pH kopolimery blokowe i lek hydrofobowy
ATE346628T1 (de) Injektionssystem für die applikation halbfester, depotförmiger pharmazeutischer zusammensetzungen aus gelierbaren peptidsalzen
HUT76788A (en) N-tert-butyl alfa-(2,4-disulfonyl)-phenyl nitrone, its salts, and their use for the preparation of pharmaceutical compositions
CA2417255A1 (en) Medicament comprising amrubicin and an anti-her2 antibody for treating breast cancer
DE1494846U (enrdf_load_stackoverflow)
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
MY124465A (en) Reduction of infarct volume using citicoline
GB1453034A (en) Pharmaceutical composition for treating spasticity
ES2156996T3 (es) Pieza añadida para un sujetador.
ZA955366B (en) Protective clothing especially antiballistic protective clothing for women
EP1690545A3 (en) Preparation of Product R and product so obtained
Dooley et al. Layer rearrangement in coextrusion
SG165152A1 (en) Chemokine receptor antagonists and methods of use thereof
PL323305A1 (en) Applications of allyl amines
RU97104062A (ru) Применение селегилина для лечения эпилептических заболеваний
HU9602041D0 (en) Oral dosage form containing colestipol as a carrier and acidic substances and a process for producing the same
EE04176B1 (et) Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks
CN211583576U (zh) 一种无扣式患者腕带
ATE386515T1 (de) Pharmazeutische zusammensetzung für die intrazelluläre ansäuerung mit cis-urocansäure
Meshnick Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies: edited by Peter P. McCann, Anthony E. Pegg, and Albert Sjoerdsma, xvi+ 371 pages. Academic Press, 1250 Sixth Ave., San Diego, California 92101. 1987
DE3376327D1 (en) Spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidine and 3'-pyrrolidino) compounds, a process for preparing the same and their use as medicaments
Chae et al. Frequency of Jsa, JSb, Kpa, KPb, Mg and Xga Blood Group Antigens among Koreans